Jacobi Capital Management LLC Lumos Pharma, Inc. Transaction History

Jacobi Capital Management LLC

  • $1.29 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$6.84 - $10.04 $34 - $50
-5 Closed
0 $0
Q2 2020

Aug 04, 2020
SELL
$7.76 - $16.99 $1,870 - $4,094
-241 Reduced 97.97%
5 $0
Q2 2020

Jul 27, 2020
BUY
$7.76 - $16.99 $1,870 - $4,094
241 Added 4820.0%
246 $0
Q1 2020

Apr 24, 2020
BUY
$0.89 - $8.85 $4 - $44
5 New
5 $0

Others Institutions Holding LUMO

# of Institutions
33
Shares Held
2.2M
Call Options Held
0
Put Options Held
0
View Full List

About LUMOS PHARMA, INC.

LUMO Quotes by TradingView
  • Ticker LUMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,396,070
  • Market Cap $36.4M
  • Description
  • Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...
More about LUMO
Track This Portfolio

Track Jacobi Capital Management LLC Portfolio

Follow Jacobi Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email